Download PDF
Synlett 2011(17): 2567-2571  
DOI: 10.1055/s-0030-1289515
LETTER
© Georg Thieme Verlag Stuttgart ˙ New York

Synthesis of Substituted 3-Cyano- and 3-(Arenesulfonyl)indoles from o-Nitrobenzyl Cyanides and Sulfones

Zbigniew Wróbel, Krzysztof Wojciechowski*
Institute of Organic Chemistry, Polish Academy of Sciences, ul. Kasprzaka 44, POB 58, 01-224 Warszawa 42, Poland
Fax: +48(22)6326681; e-Mail: krzysztof.wojciechowski@icho.edu.pl;
Further Information

Publication History

Received 19 May 2011
Publication Date:
06 October 2011 (online)

    Permissions and Reprints All articles of this category

Abstract

Formation of enamines, in the reaction of o-nitrophenyl­acetonitriles with Vilsmeier reagents, followed by reductive cyclization using Zn in acetic acid, leads to variously substituted 3-cyanoindoles, possessing aryl, alkyl, and aminoalkyl substituents at C-2. The method, when starting from the appropriate o-nitrobenzylsulfones, allows the synthesis of substituted 3-(arenesulfonyl)-­indoles.

Key words

indoles - amides - cyclization - nitriles - sulfones

    References and Notes

  • 1 Dhar TGM. Shen Z. Gu HH. Chen P. Norris D. Watterson SH. Ballentine SK. Fleener CA. Rouleau KA. Barrish JC. Townsend R. Hollenbaugh DL. Iwanowicz E. J. Bioorg. Med. Chem. Lett.  2003,  13:  3557 
    CrossrefGoogle Scholar
  • 2 Owa T. Yoshino H. Okauchi T. Okabe T. Ozawa Y. Sugi NH. Yoshimatsu K. Nagasu T. Koyanagi N. Kitoh K. Bioorg. Med. Chem. Lett.  2002,  12:  2097 
    CrossrefGoogle Scholar
  • 3 Yokoi A. Kuromitsu J. Kawai T. Nagasu T. Sugi NH. Yoshimatsu K. Yoshino H. Owa T. Mol. Cancer Ther.  2002,  1:  275 
    Google Scholar
  • 4 Turner SC. Carroll WA. White TK. Gopalakrishnan M. Coghlan MJ. Shieh C.-C. Zhang X.-F. Parihar AS. Buckner SA. Milicic I. Sullivan JP. Bioorg. Med. Chem. Lett.  2003,  13:  2003 
    CrossrefGoogle Scholar
  • 5 Garg NK. Stoltz BM. Tetrahedron Lett.  2005,  46:  1997 
    CrossrefGoogle Scholar
  • 6 Miyake FY. Yakushijin K. Horne DA. Org. Lett.  2000,  2:  2121 
    CrossrefPubMedGoogle Scholar
  • 7 Mąkosza M. Winiarski J. J. Org. Chem.  1984,  49:  1494 
    CrossrefGoogle Scholar
  • 8 Mąkosza M. Wojciechowski K. Chem. Rev.  2004,  104:  2631 
    CrossrefGoogle Scholar
  • 9a Mąkosza M. Danikiewicz W. Wojciechowski K. Liebigs Ann. Chem.  1988,  203 
    Google Scholar
  • 9b Macor JE. Forman JT. Post RJ. Ryan K. Tetrahedron Lett.  1997,  38:  1673 
    Google Scholar
  • 9c Macor JE. Wehner JM. Tetrahedron Lett.  1993,  34:  349 
    Google Scholar
  • 9d Marino JP. Hurt CR. Synth. Commun.  1994,  24:  839 
    Google Scholar
  • 10 Macor JE. Wehner JM. Tetrahedron Lett.  1991,  32:  7195 
    CrossrefGoogle Scholar
  • 11a Wróbel Z. Mąkosza M. Synlett  1993,  597 
    Google Scholar
  • 11b Wróbel Z. Mąkosza M. Tetrahedron  1997,  53:  5501 
    Google Scholar
  • 12a Suh JT. Puma BM. J. Org. Chem.  1965,  30:  2253 
    Google Scholar
  • 12b Suh JT. inventors; US  3370063. 
  • 13a Söderberg BCG. Banini SR. Turner MR. Minter AR. Arrington AK. Synthesis  2008,  903 
    Google Scholar
  • 13b Banini SR. Turner MR. Cummings MM. Söderberg BCG. Tetrahedron  2011,  67:  3603 
    Google Scholar
  • 14a Yu W. Du Y. Zhao K. Org. Lett.  2009,  11:  2417 
    Google Scholar
  • 14b Li X. Du Y. Liang Zh. Li X. Pan Y. Zhao K. Org. Lett.  2009,  11:  2643 
    Google Scholar
  • 14c El-Araby ME. Bernacki RJ. Makara GM. Pera PJ. Anderson WK. Bioorg. Med. Chem.  2004,  12:  2867 
    Google Scholar
  • 14d Orlemans EOM. Schreunder AH. Conti PGM. Verboom W. Reinhoudt DN. Tetrahedron  1987,  43:  3817 
    Google Scholar
  • 14e Wacker DA. Kasireddy P. Tetrahedron Lett.  2002,  43:  5189 
    Google Scholar
  • 15a Batcho AD. Leimgruber W. Org. Synth.  1985,  63:  214 ; Org. Synth., Coll. Vol. VII 1990, 34
    Google Scholar
  • 15b Clark RD. Repke DB. Heterocycles  1984,  22:  195 
    Google Scholar
  • 15c Gribble GW. J. Chem. Soc., Perkin Trans. 1  2000,  1045 
    Google Scholar
  • 16a Clark CI. White JM. Kelly DP. Martin RF. Lobachevsky P. Aust. J. Chem.  1998,  51:  243 
    Google Scholar
  • 16b Prashad M. Vecchia LL. Prasad K. Repic O. Synth. Commun.  1995,  25:  95 
    Google Scholar
  • 16c Coe JW. Vetelino MG. Bradlee MJ. Tetrahedron Lett.  1996,  37:  6045 
    Google Scholar
  • 17 Mąkosza M. Wróbel Z. Rev. Roum. Chim.  1991,  36:  563 ; Chem. Abstr. 1992, 117, 26036
    Google Scholar
  • 19 Mąkosza M. Goliński J. Baran J. J. Org. Chem.  1984,  49:  1488 
    CrossrefGoogle Scholar
  • 20a Wojciechowski K. Mąkosza M. Tetrahedron Lett.  1984,  25:  4793 
    Google Scholar
  • 20b Wojciechowski K. Mąkosza M. Synthesis  1986,  651 
    Google Scholar
  • 21 Heffernan GD. Coghlan RD. Manas ES. McDevitt RE. Li Y. Mahaney PE. Robichaud AJ. Huselton C. Alfinito P. Bray JA. Cosmi SA. Johnston GH. Kenney T. Koury E. Winneker RC. Deecher DC. Trybulski EJ. Bioorg. Med. Chem.  2009,  17:  7802 
    CrossrefGoogle Scholar
  • 22 Bernotas R. Lenicek S. Antane S. Zhang GM. Smith D. Coupet J. Harrison B. Schechter LE. Bioorg. Med. Chem. Lett.  2004,  14:  5499 
    CrossrefGoogle Scholar
  • 23 Bernotas RC. Antane S. Shenoy R. Le V.-D. Chen P. Harrison BL. Robichaud AJ. Zhang GM. Smith D. Schechter LE. Bioorg. Med. Chem. Lett.  2010,  20:  1657 
    CrossrefGoogle Scholar
  • 24 Wróbel Z. Wojciechowski K. Kwast A. Gajda N. Synlett  2010,  2435 
    Article in Thieme ConnectGoogle Scholar
18

General Procedure for the Synthesis of Enamines 3a,e,k The amide 2 (3 mmol) dissolved in dry MeCN (10 mL) was cooled to -40 ˚C and treated with oxalyl chloride (3 mmol). The cooling bath was removed, and the reaction mixture allowed to reach r.t. After evolution of gas ceased (ca. 30 min) the reaction mixture was cooled to -40 ˚C and treated with a solution of substrate 1 (1 mmol) and Et3N (5 mmol) in dry MeCN (10 mL). (In the case of less soluble sulfones they were added in powdered form to the cooled Vilsmeier reagent followed by the addition of Et3N). After stirring for 1 h the reaction mixture was poured into sat. NH4Cl solution (20 mL), extracted with EtOAc (3 × 20 mL), the extract was dried (Na2SO4), filtered, evaporated and purified by chromatography.
Enamines 3b-d and 3f-i were synthesized according to the procedure described previously.¹7
General Procedure for the Synthesis of 3-Cyanoindoles 4 Enamine 3 (1 mmol) in glacial AcOH (20 mL) was treated with Zn powder (10 mmol) (Note: a slight exotherm was observed). After stirring for 1 h at r.t. the mixture was heated to reflux for 1 h. After cooling the solvent was evaporated to dryness, the residue was dissolved in EtOAc (20 mL), and treated cautiously with sat. NaHCO3 (3 mL). After filtering through Celite® the solution was evaporated, and the residue purified by chromatography.
Representative Analytical Data(2 E , Z )-2-(5-Chloro-2-nitrophenyl)-3-(dimethylamino)-3-phenylacrylonitrile (3a) White solid, mp 103-106 ˚C. ¹H NMR (600 MHz, DMSO-d 6): two isomers, M (major)/N (minor) = 1.2. δ = 2.65 (s, 6 H, M), 3.18 (s, 6 H, N), 7.07 (dd, J = 8.7, 2.2 Hz, 1 H, M), 7.10-7.12 (m, 2 H, M), 7.20-7.24 (m, 2 H, M), 7.29-7.32 (m, 1 H, M), 7.33 (dd, J = 8.7, 2.2 Hz, 1 H, N), 7.43 (d, J = 2.2 Hz, 1 H, M), 7.48-7.55 (m, 5 H, N), 7.51 (d, J = 8.7 Hz, 1 H, M), 7.58 (d, J = 2.2 Hz, 1 H, N), 7.79 (d, J = 8.7 Hz, 1 H, N). MS (EI, 70 eV): m/z (%) = 327 (36), 283 (9), 187 (55), 148 (20), 118 (100), 105 (40). HRMS (EI): m/z calcd for C17H14N3O2 ³5Cl: 327.0774; found: 327. 0771.
2-{1-[(4-Methoxyphenyl)methyl]-2-methyl-5-nitro-1 H -indol-4-yl}-2-[(2 E , Z )-1-methylpyrrolidin-2-ylidene]-acetonitrile (3d) Yellow crystals, mp 165-166 ˚C (hexane-EtOAc). ¹H NMR (500 MHz, DMSO-d 6): two isomers, M (major)/N (minor) = 2.5. δ = 7.74 (d, J = 8.9 Hz, 1 H, M), 7.70 (d, J = 8.9 Hz, 1 H, N), 7.57 (d, J = 8.9 Hz, 1 H, M), 7.56 (d, J = 8.9 Hz, 1 H, N), 6.97-7.01 (m, 2 H, N), 6.93-6.97 (m, 2 H, M), 6.85-6.89 (m, 2 H, M + 2 H, N), 6.45-6.46 (m, 1 H, N), 6.39-6.40 (m, 1 H, M), 5.37-5.47 (m, 2 H, M + 2 H, N), 3.70 (s, 3 H, N), 3.69 (s, 3 H, M), 3.42-3.55 (m, 2 H, M + 2 H, N), 3.34 (s, 3 H, N), 2.92-3.08 (m, 2 H, M), 2.41 (d, J = 0.9 Hz, 3 H, N), 2.41 (d, J = 0.9 Hz, 3 H, M), 2.18 (s, 3 H, M), 2.08-2.22 (m, 2 H, N), 1.96-2.05 (m, 2 H, M), 1.70-1.76 (m, 2 H, N). MS (EI, 70 eV): m/z (%) = 416 (11), 121 (100). HRMS (EI): m/z calcd for C24H24N4O3: 416.1848; found: 416.1860.
(2 E , Z )-2-(5-Chloro-2-nitrophenyl)-3-pyrrolidin-1-ylpent-2-enenitrile (3e) Brown oil. ¹H NMR (500 MHz, DMSO-d 6): two inseparable isomers, δ = 1.14-1.24 (m, 3 H), 1.68-1.82 (m, 5 H), 2.50-2.70 (m, 2 H), 2.90-3.15 (m, 3 H), 7.45 (br s, 1 H), 7.53-7.59 (m, 1 H), 7.94 (d, J = 8.4 Hz, 1 H). MS (EI, 70 eV): m/z (%) = 305 (31), 235 (12), 165 (100), 110 (15). HRMS (EI): m/z calcd for C15H16N3 ³5ClO2: 305.0931; found: 305.0933.
5-Chloro-2-phenyl-1 H -indole-3-carbonitrile ( 4a) Pale yellow solid, mp >260 ˚C. ¹H NMR (500 MHz, DMSO-d 6): δ = 7.33 (dd, J = 8.6, 1.9 Hz, 1 H), 7.56-7.60 (m, 2 H), 7.62-7.68 (m, 3 H), 7.96-7.99 (m, 2 H), 12.80 (br s, 1 H). ¹³C NMR (125 MHz, DMSO-d):²5 δ = 81.7, 114.8, 116.8, 118.0, 124.5, 127.2, 127.6, 129.4, 129.8, 130.8, 134.6, 146.6. MS (EI, 70 eV): m/z (%) = 252 (100), 217 (11), 190 (14). HRMS (EI): m/z calcd for C15H9N2 ³5Cl: 252.0454; found: 252.0449.
6-[(4-Methoxyphenyl)methyl]-7-methyl-2-[3-(methyl-amino)propyl]-3 H ,6 H -pyrrolo[3,2- e ]indole-1-carbonitrile ( 4d) Pale yellow crystals, mp 177 ˚C (dec., EtOH). ¹H NMR (500 MHz, DMSO-d 6):²6 δ = 1.87-1.94 (m, 2 H), 2.32 (s, 3 H), 2.41 (s, 3 H), 2.58 (t, J = 7.0 Hz, 2 H), 2.93 (t, J = 7.4 Hz, 2 H), 3.67 (s, 3 H), 5.36 (s, 2 H), 6.55 (s, 1 H), 6.82-6.85 (m, 2 H), 6.89-6.93 (m, 2 H), 7.10 (d, J = 8.7 Hz, 1 H), 7.23 (d, J = 8.7 Hz, 1 H). ¹³C NMR (125 MHz, DMSO-d): δ = 13.0, 25.1, 28.6, 35.7, 45.9, 50.5, 55.5, 81.6, 97.7, 106.0, 106.9, 114.4, 118.3, 118.5, 119.1, 127.8, 129.6, 130.8, 132.4, 136.1, 147.1, 158.7. MS (EI, 70 eV): m/z (%) = 386 (39), 355 (12), 121 (100). HRMS (EI): m/z calcd for C24H26N4O: 386.2107; found: 386.2098.
5-Chloro-2-ethyl-1 H -indole-3-carbonitrile ( 4e) White crystals, mp 176-182 ˚C. ¹H NMR (500 MHz, DMSO-d 6): δ = 1.33 (t, J = 7.6 Hz, 3 H), 2.91 (t, J = 7.6 Hz, 2 H), 7.23 (dd, J = 8.6, 2.0 Hz, 1 H), 7.47 (d, J = 8.6 Hz, 1 H), 7.54 (d, J = 2.0 Hz, 1 H), 12.28 (br s, 1 H). ¹³C NMR (125 MHz, DMSO-d): δ = 13.1, 20.4, 81.7, 113.7, 115.7, 117.1, 122.8, 126.1, 128.3, 133.3, 152.8. MS (EI, 70 eV): m/z (%) = 204 (46), 189 (100). HRMS (EI): m/z calcd for C11H9N2 ³5Cl: 204.0454; found: 204.0463
2-(Dimethylamino)-1 H -benzo[ g ]indole-3-carbonitrile (5) ²7 Yellow solid. MS (EI, 70 eV): m/z (%) = 235 (100), 220 (54), 192 (24), 164 (8). HRMS (EI): m/z calcd for C15H13N3: 235.1110; found: 325.1103.
5-Chloro-2-ethyl-1-hydroxy-1 H -indole-3-carbonitrile ( 7e) Colorless crystals, mp 177-183 ˚C (hexane-EtOAc). ¹H NMR (500 MHz, DMSO-d 6): δ = 1.32 (t, J = 7.6 Hz, 3 H), 2.93 (q, J = 7.6 Hz, 2 H),7.31 (dd, J = 8.7, 2.0 Hz, 1 H), 7.55 (dd, J = 8.7, 0.6 Hz, 1 H), 7.60 (dd, J = 2.0, 0.6 Hz, 1 H), 12.07 (s, 1 H). ¹³C NMR (125 MHz, DMSO-d): δ = 13.1, 18.6, 77.4, 111.7, 115.7, 117.8, 123.7, 124.2, 127.2, 131.7, 149.5. MS (EI, 70 eV): m/z (%) = 220 (100), 205 (46), 189 (46). HRMS (EI): m/z calcd for C11H9N2 ³5ClO: 220.0403; found: 220.0405.

25

One carbon resonance was not observed.

26

N-H signals not visible.

27

Compound 5 was isolated in insufficient quantities to obtain full analytical data.